Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like New noninvasive technique can quickly collect 3D images of the human body January 16, 2026 CB1R inhibition shows promise in protecting gut barrier from alcohol damage March 19, 2025 Study finds no increased risk from vaccine aluminum exposure July 15, 2025